EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.31X leverage
Emcure Pharmaceuticals live price: ₹1453.4. It opened at ₹1,482 vs previous close ₹1,467; intraday high/low: ₹1,491/₹1,434. The 50 & 200 DMA stand at ₹1,461.84/₹1,396.94.
Emcure Pharmaceuticals Performance
- Low
- ₹1,434
- High
- ₹1,491
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,586
- Open Price₹1,482
- Previous Close₹1,467
- Volume87,294
- 50 DMA₹1,461.84
- 100 DMA₹1,435.40
- 200 DMA₹1,396.94
Investment Returns
- Over 1 Month -5.31%
- Over 3 Month + 3.56%
- Over 6 Month + 6.03%
- Over 1 Year + 53.62%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 31.7
- PEG Ratio
- 0.7
- Market Cap Cr
- 27,555
- P/B Ratio
- 5.5
- Average True Range
- 51.11
- EPS
- 47.73
- Dividend Yield
- 0.2
- MACD Signal
- -9.18
- RSI
- 47.28
- MFI
- 71.45
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,453.40
-13.5
(-0.92%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹1,462.43
- 50 Day
- ₹1,461.84
- 100 Day
- ₹1,435.40
- 200 Day
- ₹1,396.94
Resistance and Support
1459.33
- R3 1,542.47
- R2 1,516.73
- R1 1,485.07
- S1 1,427.67
- S2 1,401.93
- S3 1,370.27
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,453 As on 06 March, 2026 | 07:45
The Market Cap of Emcure Pharmaceuticals is ₹27554.9 Cr As on 06 March, 2026 | 07:45
The P/E ratio of Emcure Pharmaceuticals is 31.7 As on 06 March, 2026 | 07:45
The PB ratio of Emcure Pharmaceuticals is 5.5 As on 06 March, 2026 | 07:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.